Yoon Ah Cho1,2, Sangjoon Choi1, Sujin Park1, Cheol-Keun Park1,3, Sang Yun Ha4. 1. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. 2. Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Republic of Korea. 3. Anatomic Pathology Reference Lab, Seegene Medical Foundation, Seoul, Republic of Korea. 4. Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea sangyun.ha@skku.edu.
Abstract
BACKGROUND/AIM: Pregnancy up-regulated non-ubiquitous calmodulin kinase (PNCK) is a member of calmodulin kinase, and overexpression of PNCK with involvement in carcinogenesis have been reported in HER-2 amplified breast cancer, clear cell renal cell carcinoma and nasopharygeal carcinoma. However, the expression of PNCK and its clinical implication have not been elucidated in hepatocellular carcinoma (HCC). MATERIALS AND METHODS: We investigated PNCK expression at both the protein and mRNA level using immunohistochemistry (IHC) and microarray gene expression profiling in HCC tissue samples, and evaluated its association with clinicopathological parameters and their potential prognostic significance. RESULTS: High PNCK protein expression and high PNCK mRNA level was observed in 61.7% and 34.7% of total HCC cases, respectively. PNCK mRNA level was higher in tumor tissues than in background non-tumor tissues, and significantly correlated with protein expression by IHC. High PNCK expression was associated with higher Edmondson grade, intrahepatic metastasis, microvascular invasion and higher AFP levels. Patients with high PNCK expression showed shorter recurrence-free survival and disease-specific survival, and high mRNA expression of PNCK was an independent prognostic factor in disease-specific survival. CONCLUSION: Up-regulation of PNCK expression as well as its association with poor prognosis was demonstrated in HCC. PNCK might be a prognostic biomarker of HCC, and could be a potential candidate therapeutic target. Copyright
BACKGROUND/AIM: Pregnancy up-regulated non-ubiquitous calmodulin kinase (PNCK) is a member of calmodulin kinase, and overexpression of PNCK with involvement in carcinogenesis have been reported in HER-2 amplified breast cancer, clear cell renal cell carcinoma and nasopharygeal carcinoma. However, the expression of PNCK and its clinical implication have not been elucidated in hepatocellular carcinoma (HCC). MATERIALS AND METHODS: We investigated PNCK expression at both the protein and mRNA level using immunohistochemistry (IHC) and microarray gene expression profiling in HCC tissue samples, and evaluated its association with clinicopathological parameters and their potential prognostic significance. RESULTS: High PNCK protein expression and high PNCK mRNA level was observed in 61.7% and 34.7% of total HCC cases, respectively. PNCK mRNA level was higher in tumor tissues than in background non-tumor tissues, and significantly correlated with protein expression by IHC. High PNCK expression was associated with higher Edmondson grade, intrahepatic metastasis, microvascular invasion and higher AFP levels. Patients with high PNCK expression showed shorter recurrence-free survival and disease-specific survival, and high mRNA expression of PNCK was an independent prognostic factor in disease-specific survival. CONCLUSION: Up-regulation of PNCK expression as well as its association with poor prognosis was demonstrated in HCC. PNCK might be a prognostic biomarker of HCC, and could be a potential candidate therapeutic target. Copyright
Authors: Ho-Yeong Lim; Insuk Sohn; Shibing Deng; Jeeyun Lee; Sin Ho Jung; Mao Mao; Jiangchun Xu; Kai Wang; Stephanie Shi; Jae Won Joh; Yoon La Choi; Cheol-Keun Park Journal: Ann Surg Oncol Date: 2013-06-26 Impact factor: 5.344
Authors: H P Gardner; J V Rajan; S I Ha; N G Copeland; D J Gilbert; N A Jenkins; S T Marquis; L A Chodosh Journal: Genomics Date: 2000-01-15 Impact factor: 5.736
Authors: T Kumada; S Nakano; I Takeda; K Sugiyama; T Osada; S Kiriyama; Y Sone; H Toyoda; S Shimada; M Takahashi; T Sassa Journal: Hepatology Date: 1997-01 Impact factor: 17.425
Authors: Tushar B Deb; Christine M Coticchia; Robert Barndt; Hong Zuo; Robert B Dickson; Michael D Johnson Journal: Am J Physiol Cell Physiol Date: 2008-06-18 Impact factor: 4.249